Introducing the INSPIRA™ ART100 from Inspira Technologies
In a remarkable advancement for medical technology, Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) has launched the INSPIRA™ ART100 system. This exciting announcement comes as part of the 34th Annual Extracorporeal Life Support Organization (ELSO) Conference. Known for its pioneering work in extracorporeal blood circulation technologies, Inspira Technologies is reinforcing its dedication to innovation with this new release.
Interactive Demonstrations at the ELSO Conference
Attendees of this esteemed conference will have the opportunity to take part in interactive demonstrations featuring the INSPIRA™ ART100. This system has received clearance from the U.S. Food and Drug Administration (FDA) and is designed to enhance patient care through hands-on experiences with this cutting-edge technology. Attendees will also have the chance to engage with notable team members from Inspira, including VP of Product, Mr. Tomer Carmeli, and Medical Director, Dr. Dekel Stavi, who will address questions related to the innovative features of the INSPIRA™ ART100 system.
Visit Us at Booth #18
We invite healthcare professionals to come to booth #18 for an in-depth look at the INSPIRA™ ART100 and discover its unique advantages. The U.S. sales team will be present alongside Glo-Med Networks Inc., the primary distributor and after-market service provider for Inspira, to demonstrate how this system can enhance operations within leading hospitals and medical institutions.
Understanding the Extracorporeal Life Support Organization (ELSO)
ELSO is a global nonprofit consortium that is passionate about supporting those who deliver extracorporeal life support. Their mission focuses on promoting continuous education, establishing guidelines, and facilitating original research that benefits the ECMO (extracorporeal membrane oxygenation) community, which encompasses over 20,000 members worldwide. This organization plays a vital role in connecting healthcare professionals across various backgrounds, ultimately enhancing practices in this crucial medical field.
Leading the Way in Respiratory Treatment
Inspira Technologies stands at the cutting edge of innovation in respiratory treatment with its Augmented Respiration Technology (ART). This technology aims to optimize patient oxygen levels while reducing the need for invasive mechanical ventilation methods, greatly improving patient comfort and care. The INSPIRA™ ART100 system, equipped with real-time blood monitoring capabilities, enables healthcare providers to make informed and timely clinical decisions.
Future Product Developments
The company is also committed to developing other important products, including the INSPIRA™ ART500 and the innovative HYLA™ blood sensor. Although these technologies are still in the design phase and have not yet been tested on humans, they hold great potential to further transform patient care.
Contacting the Company
For any questions or media inquiries, representatives from Inspira Technologies can be reached via email at info@inspirao2.com or by calling +972-9-9664485.
Frequently Asked Questions
What is the INSPIRA™ ART100?
It's a groundbreaking system for extracorporeal blood circulation, launched recently by Inspira Technologies.
Where can I see the INSPIRA™ ART100 in action?
The INSPIRA™ ART100 will be on display at the ELSO Conference, specifically at booth #18, where attendees can interact with the technology.
Who are the key figures behind the INSPIRA™ ART100?
Key team members include Tomer Carmeli (VP of Product), Dr. Dekel Stavi (Medical Director), and Dr. Daniella Yeheskely-Hayon (CTO).
What organizations contribute to the ELSO Conference?
The conference is backed by an international nonprofit consortium comprising medical institutions, researchers, and industry partners focused on life support initiatives.
How does the INSPIRA™ ART100 improve patient care?
The system enhances patient care through real-time blood monitoring, aiming to balance oxygen saturation levels while minimizing the need for invasive procedures.
